Auto-injectors Market Size & Share, by Product Type (Disposable, Reusable); Disease Indication (Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, Anaphylaxis); End-Use (Home Care Settings, Hospitals & Clinics, Ambulatory Surgical Centers); Technology (Manual, Automatic); Route of Administration (Subcutaneous, Intramuscular) – Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2024-2036

In the News

• Eli Lilly and Company announced that it has received approval from the U.S. Food and Drug Administration (FDA) for Mounjaro (tirzepatide) injection a single molecule that activates the body's receptors for GIP and GLP-1 for people living with type 2 diabetes to assist individuals in obtaining the prescription drugs they are prescribed, and it will collaborate with physicians, insurers, and health systems to facilitate patient access to Mounjaro.
• Stevanato Group together with Owen Mumford to expedite the Aidaptus auto-injector's manufacturing process and also provide pharmaceutical clients with pre-filled syringes so they may administer the finished product to patients.